Buy this domain?
Click Here

May 2021
M T W T F S S
     
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Search

are.my
Graft-versus-host disease
Graft-versus-host disease (GvHD) is a syndrome, characterized by inflammation in different organs. GvHD is commonly associated with bone marrow transplants
Transfusion-associated graft-versus-host disease
Transfusion-associated graft-versus-host disease (TA-GvHD) is a rare complication of blood transfusion, in which the immunologically competent donor T
Lichen planus
a lichenoid reaction. They can also occur in association with graft versus host disease. Lichen planus lesions are so called because of their "lichen-like"
Hematopoietic stem cell transplantation
radiation or chemotherapy before the transplantation. Infection and graft-versus-host disease are major complications of allogeneic HSCT. HSCT remains a dangerous
Anti-thymocyte globulin
is frequently given at the time of the transplant to prevent graft-versus-host disease, although many European centers prefer to reserve its use for
Sirolimus
DA (June 1998). "Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production
Inflammatory cytokine
involved the detrimental effects of renal fibrosis.[citation needed] Graft-versus-host disease (GvHD) targets JAK 1 and 2, the human tyrosine kinase protein
Cyclophosphamide
people who are ill-suited for autologous stem cell transplant. Graft-versus-host disease (GVHD) is a major barrier for allogeneic stem cell transplant
Alemtuzumab
(no controls) with severe steroid-resistant acute intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation (HSCT)
Transplant rejection
mediate allograft rejection via the CD4 and CD8 T cells. Graft-versus-host disease Graft-versus-tumor effect Immunosuppression Transplant engineering Frohn